Center for Drug Safety and Effectiveness
Drawing on the combined expertise of the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine, the Center for Drug Safety and Effectiveness serves as a nexus for individuals at Johns Hopkins who are involved in research, education, clinical programs and public service to improve prescription drug use and pharmaceutical policy in the United States and around the world. The unparalleled knowledge base of the Center’s core faculty reflects a diversity of fields, ranging from pharmacovigilance to regulatory policy.
Welcome
The Center for Drug Safety and Effectiveness seeks to improve the safe and effective use of medications through a fourfold mission – training, research, patient care and public service – towards best medication practices.
Upcoming
2024-2025 "Safety, Value and Innovation" Seminar Series
December 9, 2024, 12-1pm
Speaker: Rahul Shenolikar, PhD, MS (AstraZeneca)
Training
The Center for Drug Safety and Effectiveness is training the next generation of leaders in pharmacoepidemiology and drug safety. The Center supports a diverse group of trainees, from masters' and doctoral students to clinical residents, fellows and junior faculty.